ABOUT THE CONFERENCE

The 6th National Tishk Pharmaceutical Conference (NTPC 2026), which will be hosted by the Faculty of Pharmacy at Tishk International University in Erbil, Iraq, is dedicated to exploring the transformative effects of advanced cancer therapies on health, economic resilience, and environmental sustainability. With the theme “Sustainable Development Perspectives in Cancer Care: Emerging Global Trends and Therapeutic Advancements,” the conference will emphasize the integration of cutting-edge pharmaceutical research with the United Nations Sustainable Development Goals. The 6th NTPC 2026 will serve as a vibrant platform for scientific exchange, policy dialogue, and collaborative innovation, aiming to promote equitable healthcare and foster interdisciplinary partnerships within the pharmaceutical sciences.

 

OBJECTIVES OF 6th NTPC 2026

NTPC 2026 is a forward-thinking initiative that pushes the boundaries of pharmaceutical science, with a strong emphasis on sustainable development. The conference is designed to achieve the following objectives:

  • Promote Scientific Exchange and Innovation:

Encourage the sharing of authoritative insights and groundbreaking ideas among leading scientists in both traditional and modern drug discovery, with a focus on translational research and therapeutic innovation.

  • Advanced Cancer Therapeutics for Sustainable Health:

Emphasizing the transformative impact of advanced cancer therapies in achieving Good Health and Well-Being (SDG-3), while exploring their potential contributions to economic resilience and environmental sustainability.

  • Catalyze National Scientific Collaboration:

Bringing together scientific experts from across the nation to share cutting-edge research findings, foster interdisciplinary dialogue, and stimulate collaborative efforts in drug development and cancer treatment.

  • Strengthening cross-cultural and regional networks:

Offering a dynamic platform for building cross-cultural relationships and regional partnerships that enhance scientific understanding and promote inclusive innovation.

  • Bridge Science and Policy (Partnerships for the Goals (SDG-17)):
  • Encourage inclusive multisectoral collaboration that effectively integrates scientific research, policy development, and community engagement to accelerate therapeutic innovation.
  • Address structural inequities and access barriers that limit the availability and affordability of advanced cancer treatments, particularly for marginalized and underserved populations.
  • Promote fair development and allocation of new treatments through strategies that ensure equal access, guaranteeing that scientific progress leads to significant health benefits for all patients.

Collectively, these strategic actions affirm the commitment of NTPC 2026 to strengthening resilient healthcare systems and fostering inclusive scientific networks, in line with the principles of Sustainable Development Goal 17: Partnerships for the Goals.

THE SCOPE OF NTPC 2026

The National Tishk Pharmaceutical Conference (NTPC 2026) offers a comprehensive and interdisciplinary platform for advancing pharmaceutical sciences, with a central focus on therapeutic innovation in cancer care and its alignment with the United Nations Sustainable Development Goals (SDGs). This conference is designed to convene leading experts from academia, industry, and clinical practice to explore:

  • Advanced cancer therapies and their role in promoting health, economic sustainability, and environmental stewardship
  • Innovations in drug discovery and development, including targeted therapies, biologics, and personalized medicine
  • Cutting-edge pharmacological regimens and their translational potential in oncology and chronic disease management
  • Medicinal chemistry and molecular design for next-generation therapeutics
  • Natural products and phytopharmaceuticals as emerging contributors to cancer treatment and drug innovation
  • Interdisciplinary collaboration across pharmaceutical, clinical, and policy domains to foster equitable access and global health impact

By showcasing pioneering research and fostering cross-sectoral dialogue, NTPC 2026 aims to accelerate scientific progress, strengthen collaborative networks, and catalyze sustainable, patient-centered solutions in pharmaceutical care.

 

OUTCOMES OF NTPC 2026

After participating in this conference, participants will be able to:

  • Recognize and evaluate emerging therapeutic strategies in cancer treatment and pharmaceutical innovation.
  • Strengthen collaborative networks between academic institutions and the pharmaceutical industry to foster translational research.
  • Articulate the stages and dynamics of the drug discovery cascade, from target identification to clinical application.
  • Distinguish between traditional and contemporary approaches in drug discovery, highlighting methodological evolution.
  • Assess the impact of modern tools and technologies such as AI, high-throughput screening, and molecular modelling on drug development.
  • Explore current trends, innovations, and challenges in drug formulation and targeted drug delivery systems related to cancer therapy.

 

TARGETED PARTICIPANTS

NTPC 2026 welcomes a diverse range of participants from across the pharmaceutical and healthcare ecosystem, including:

  • Academic staff from pharmacy and health sciences disciplines
  • Scientists engaged in pharmaceutical research and development
  • Undergraduate and postgraduate pharmacy students
  • Ph.D. scholars in medical and paramedical fields
  • Practicing pharmacists and clinical professionals
  • Experts from the pharmaceutical industry and manufacturing sectors
  • Professors and educators in medical and allied sciences
  • Clinical data scientists, analysts, and laboratory specialists
  • Representatives from pharmaceutical companies and associations
  • Healthcare analysts, pathologists, and regulatory professionals

 

 

 

PATRON’S

Asst. Prof. Dr. Idris Hadi Salih

(Head of Board of Trustees, TIU, Erbil, Iraq)

&

Prof. Dr. Sultan Abu Orabi

(President, TIU, Erbil, Iraq)

 

ADVISORY BOARD MEMBERS

Asst. Prof. Dr. Mehmet Ozdemir, Vice President (Academic Affairs), TIU, Erbil

Asst. Prof. Dr. Abdul Samad Salahuddin, Dean, Faculty of Pharmacy, TIU, Erbil

Prof. Dr. Faiq H.S. Hussain, Dean, Faculty of Science, TIU, Erbil

Prof. Dr. Jafar Naghshbandi, Dean, Faculty of Dentistry, TIU, Erbil

Prof. Dr. Hiwa Bana, Dean, Faculty of Nursing, TIU, Erbil

Dr. Orhan Tug, Director of Research Center, TIU, Erbil

Dr. Fatih Cura, Vice President (Admin Affairs and Finance), TIU, Erbil

 

ORGANIZING COMMITTEE

Dr. Kamran Javed Naquvi (Chair)

Assistant Professor, Faculty of Pharmacy, TIU, Erbil

Dr. Subhasini Uthirapathy (Member)

Assistant Professor, Faculty of Pharmacy, TIU, Erbil

Dr. Rojan Arif (Member)

Assistant Lecturer, Faculty of Pharmacy, TIU, Erbil

Dr. Shajwan Salar (Member)

Assistant Lecturer, Faculty of Pharmacy, TIU, Erbil

Dr. Dania Awni (Member)

Assistant Lecturer, Faculty of Pharmacy, TIU, Erbil

 

CONFERENCE COMMITTEES

SCIENTIFIC COMMITTEE

Dr. Javed Ahamad (Head)

Assistant Professor, Faculty of Pharmacy, TIU, Erbil

Dr. Subhasini Uthirapathy (Member)

Assistant Professor, Faculty of Pharmacy, TIU, Erbil

Dr. Esra Tariq Anwer (Member)        

Assistant Lecturer, Faculty of Pharmacy, TIU, Erbil

Dr. Mohammad Javed Naim (Member)

Assistant Professor, Faculty of Pharmacy, TIU, Erbil

Professor Dr. Nabeel A. Fakhre (External Member)

Department of Chemistry, University of Salahaddin, Erbil

Dr. Tareq Waece Sadiq (External Member)

Lecturer, Department of Pharmacy, Erbil Polytechnic University, Erbil

Dr. Dana Mohammad (External Member)

Head, Clinical Pharmacy Department, HMU, Erbil

 

EDITORIAL COMMITTEE

Dr. Javed Ahamad (Head)

Ms. Louna (Member)

 

HOSPITALITY COMMITTEE

Dr. Sardar Dyan (Head)

Dr. Rozhan Arif (Member)

Dr. Mohammad Aslam (Member)

 

REGISTRATION AND CERTIFICATION COMMITTEE

Dr. Zahraa Saad Tahsin (Head)

Dr. Peshawa Osw (Member)

 

WEB COMMITTEE

Mr. Omar Najmaddin (Head)

Ms. Abeer (Member)

 

SPONSORSHIP COMMITTEE

Dr. Ahmad Hamdy (Head)

Abstract Submission Guidelines

  1. General Requirements
  • All abstracts must be submitted electronically through the official conference email ID Abstract Submission Email: ntpc@tiu.edu.iq
  • Submissions must be original and not previously published or presented elsewhere.
  • Each participant may submit one primary abstract as the presenting author (*); additional abstracts may be submitted as co-authors.
  1. Abstract Structure

Abstracts should follow the standard scientific format:

  • Title: Clear, concise, and accurately reflecting the study.
  • Authors and Affiliations: Include full names, institutional affiliations, and email of the corresponding author.
  • Background/Introduction: Brief context or rationale.
  • Objectives/Purpose: What the study aims to investigate.
  • Methods: Key methods, materials, or approach.
  • Results: Main findings (can be preliminary; avoid vague statements).
  • Conclusion: Key takeaway or relevance.
  • Keywords: 3–5 relevant terms.
  1. Formatting Instructions
  • Maximum word limit: 300-350 words (excluding title and authors).
  • Font: Times New Roman, size 12.
  • Spacing: Single-spaced.
  • Language: English
  • No tables, figures, or references in the abstract body.
  1. Ethical Considerations
  • Research involving humans, animals, or clinical samples must state ethical approval.
  • Presenters are responsible for the accuracy of data and compliance with research ethics.
  1. Review Process
  • All submitted abstracts will undergo peer review by the Scientific Committee.
  • Evaluation criteria include:
    • Originality and significance
    • Scientific clarity and methodology
    • Relevance to conference themes
  • Decision categories: Accepted for (Poster Presentation, Full paper Publication), Revision Required, or Rejected.
  1. Presentation Requirements
  • Poster presenters must follow the conference’s poster size and formatting guidelines.
  • All the authors of the accepted abstract must register for the conference.

 

 

 

 

 

 

 

Abstract Submission & Registration:

  • Last date for Abstract submission for Poster: 8 March 2026
  • Abstract acceptance date: 20 March 2026
  • Online registration started from date: 01 April 2026
  • 6th NTPC 2026 dates: 25-26 April 2026

 

(Expected number of invitees/ attendees = 250 approx.)

 

Abstract Submission Email: ntpc@tiu.edu.iq